Companies
Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
![](/-/media/editorial/generics/2020/04/gb2004_fda_hq_1633674832_1200.jpg?rev=ac91e68c492f42408ddf3e9662fd109a&w=350&hash=E0FC73AE3420A6FC49426A07441F083E)
Philips Disputes Additional Deaths Linked To May Recall Of Breathing Machines
The US FDA is reporting dozens more additional deaths associated with a May recall of Philips ventilators than initially reported. The company says it stands by its original number of seven and has reached out to the FDA.
![](/-/media/editorial/medtech-insight/2024/06/mti-entrydenied-1200.jpg?rev=73a9a1d06e8048bca705bb100e754acd&w=350&hash=0D9EA26E7A5AA319843EEFBDEF29837C)
FDA Finalizes Definitions Of Delaying Or Denying Inspections
The US FDA has issued its final guidance defining manufacturer behaviors it deems as hampering the agency’s ability to conduct an inspection. In a previous draft guidance, the agency expanded its longstanding policy on inspections of drug companies to include device makers as well.
![](/-/media/editorial/medtech-insight/2024/06/mti-teleflex-1200.jpg?rev=023b0454716a4a5eac6e829af6bc4e0d&w=350&hash=BAB6AB16AD0CB8BE210A600404175934)
3 Deaths Linked To Latest Teleflex Catheter Recall
Teleflex is recalling thousands of intra-aortic balloon catheter kits that are used during cardiac procedures and to treat complications from heart failure. This is the latest in a series of recalls from Teleflex and its subsidiary Arrow International.
![](/-/media/editorial/medtech-insight/2024/06/mti2406_medtechbrain_bio_banner_1200.png?rev=fba3f341049f4853a5cbc7743c6bba55&w=350&hash=5F3B4F4B9E31872CDE789F4C14A27049)
ADDF Leaders Discuss Future Strategies In Alzheimer’s Research And Crucial Role Of Diagnostic Markers
Medtech Insight talked to two leaders at the Alzheimer’s Drug Discovery Foundation about current therapies and the role of biomarkers and digital tools to build on recent advancements in the space and accelerate progress to identify the disease early and slow cognitive decline.
![](/-/media/editorial/medtech-insight/2024/06/mti-madeinchina-1200.jpg?rev=854b9033a36545f280926a4e9af9771d&w=350&hash=72F1D3FA99EC4A15CBA0B5C467C2F799)
Biden’s China Tariffs Mark A Major Shift In US Policy, Analysts Say
A new round of tariffs imposed by the Biden administration on various Chinese goods, including medical devices, points to a broader shift in US strategy for strengthening supply chains and ensuring Americans have reliable access to safe products, according to analysts who spoke to Medtech Insight about the tariffs. While fueled by the pandemic, the momentum pushing this change in trade policy has been growing for some time.
![](/-/media/editorial/medtech-insight/2024/06/mti-zetoonedevice1-1200.jpg?rev=069ac475f8fe4d1fbc01b2235b180044&w=350&hash=3A0048EFD0D1A5B44C5CD80AE279BF80)
Zeto Wins FDA Clearance For Novel Seizure Detection Device
The US FDA has granted 510(k) clearance to a California medical technology company for a brain monitoring device that detects seizures in patients with brain injury or trauma.
![](/-/media/editorial/medtech-insight/2024/05/mti-maculardegeneration-1200.jpg?rev=421cb4c089434d1abef9b9d611ac5d70&w=350&hash=0B525B9F51971D529AF3367261222700)
FDA Grants De Novo Marketing Authorization For At-Home Retinal Imaging Device
Notal Vision, a Virginia-based patient-centric ophthalmic remote monitoring services provider, has won de novo marketing authorization from the US FDA for a product that allows patients to keep tabs on their age-related macular degeneration while at home.
![](/-/media/editorial/medtech-insight/2024/05/mt2405_baby-wearables_498286150.jpg?rev=ac93662578bb470887daa4809a9139bc&w=350&hash=9FBE068D78EB1DD92B8A6EA431043431)
US FDA Clearance For Masimo’s Stork Delivers OTC Baby Monitoring Tech Competition
Masimo receives US regulatory clearance for Stork OTC baby monitoring system six months after Owlet received first clearance for its Dream Sock following a regulatory stumble which halted sales of a previous device, Smart Sock, in 2021.
![](/-/media/editorial/medtech-insight/2024/05/mti-diabetes-1200.jpg?rev=5999e256773d4d4da7074076c8b83fb1&w=350&hash=3EDF118E8BF0DF77A57251383E13E41F)
Senseonics Wins Marketing Authorization For Novel Insulin Delivery System
The US FDA has cleared a glucose monitoring system from Senseonics. The authorization of the implantable insulin delivery system creates a new pathway for like devices.
![](/-/media/editorial/medtech-insight/2024/04/mt2404_sterilization_1268263639_1200.jpg?rev=97c0713868c945a28249c47a31a634e7&w=350&hash=516869D9008640780AC1926DE57BA348)
Small Sterilization Companies Poised To Meet EtO Emissions Goals On Time
Small sterilizers told Medtech Insight that they were ready for the EPA’s controversial EtO emissions rule, while community advocates expressed concerns.
![](/-/media/editorial/hbw-insight/2024/04/hbw2404_wearables_s_1438621610.jpg?rev=db15c5fcd84e40dca5f914771a5e2dd6&w=350&hash=B4A2F5E8882B9BFC7A50E2C8053E8073)
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
![](/-/media/editorial/medtech-insight/2024/04/mti2404_alzheimers_2187613251_1200.jpg?rev=e6566b43b1c94a759a6f112666e1eda0&w=350&hash=3D9D1BBEFAF6B53ECC77BBC34119A648)
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.
![](/-/media/editorial/medtech-insight/2024/04/mti-diabetesawareness-1200.jpg?rev=256e6ad86cda4b519583038530ef4f21&w=350&hash=C6E51B6E3690B860048F5AB150DF0841)
Alarming Rise Of Diabetes in Several US States, Study Shows
A study of diabetes rates across the US over four years reveals significant increases in the disease in many states. Tobias Oerum, diabetes advocate and cofounder of the company that conducted the study, discussed the data and some of the factors contributing to this troubling trend with Medtech Insight.
![](/-/media/editorial/medtech-insight/2024/04/mti-bonemarrowstudy-1200.jpg?rev=a7a69f32db2a4c49882d1e6c8858536a&w=350&hash=5B0D56E1ACCDCFF3478128E3A8494E1D)
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.
![](/-/media/editorial/products/o/osteoadapt_1200.png?rev=03951760ee094091b8421e09553f2fb5&w=350&hash=0E158F92BFE3D65FAF10665F1D63F484)
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Implant
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
![](/-/media/editorial/medtech-insight/2024/04/mti-consentdecree-1200.jpg?rev=07b96b5529e84a0c851cdf4c46b3ee36&w=350&hash=3AB327AB4D0662225DDBB21A6887CC4B)
Consent Decree Against Philips Entered In Federal Court, Outlines ‘Roadmap’ For Compliance
A consent decree agreed to in January between Royal Philips and the US government is now official. The decree stems from a recall in 2021 of millions of the company’s sleep therapy and breathing devices due to risks posed by the sound abatement foam inside the machines.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.